TCRX — TScan Therapeutics, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-07-15.
Performance
Technicals
Others in Healthcare
Measured signals that fired on TCRX
| date | signal | measured base rate |
|---|---|---|
| 2026-07-14 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2025-12-23 | Lynx1 Capital Management LP | Open-market purchase | 6.2K | 0.90 | 5.6K |
| 2025-12-23 | Nichols Weston | Open-market purchase | 6.2K | 0.90 | 5.6K |
| 2025-12-22 | Lynx1 Capital Management LP | Open-market purchase | 75.5K | 0.90 | 68.0K |
| 2025-12-22 | Nichols Weston | Open-market purchase | 75.5K | 0.90 | 68.0K |
| 2025-12-19 | Nichols Weston | Open-market purchase | 80.1K | 0.90 | 72.1K |
| 2025-12-19 | Lynx1 Capital Management LP | Open-market purchase | 80.1K | 0.90 | 72.1K |
| 2025-05-20 | Nichols Weston | Open-market purchase | 1.2M | 1.20 | 1.4M |
| 2025-05-20 | Lynx1 Capital Management LP | Open-market purchase | 1.2M | 1.20 | 1.4M |
| 2025-05-19 | Lynx1 Capital Management LP | Open-market purchase | 1.4M | 1.20 | 1.7M |
| 2025-05-19 | Nichols Weston | Open-market purchase | 1.4M | 1.20 | 1.7M |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Lynx1 Capital Management LP | 8.1M | 8.0M |
| BVF INC/IL | 5.6M | 5.6M |
| BAKER BROS. ADVISORS LP | 2.8M | 2.8M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.2M | 2.2M |
| BlackRock, Inc. | 1.9M | 1.8M |
| MILLENNIUM MANAGEMENT LLC | 1.5M | 1.5M |
| RENAISSANCE TECHNOLOGIES LLC | 1.4M | 1.4M |
| Deer Management Co. LLC | 1.3M | 1.2M |
| TWO SIGMA INVESTMENTS, LP | 1.2M | 1.2M |
| Aberdeen Group plc | 927.2K | 918.0K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 8-K | 2026-08-18 | 2026-08-12 | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-08-14 | — | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-08-14 | — | on EDGAR ↗ |
| 10-Q | 2026-08-12 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-08-12 | 2026-08-12 | on EDGAR ↗ |
| 8-K | 2026-06-22 | 2026-06-22 | on EDGAR ↗ |
| 4 | 2026-05-22 | 2026-05-20 | on EDGAR ↗ |
| 8-K | 2026-05-22 | 2026-05-20 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Tscan Therapeutics, Inc. (TCRX) filed form 8-K · 2026-08-18 · SEC EDGAR
- TScan Therapeutics, Inc. (TCRX) filed form 8-K · 2026-08-18 · SEC EDGAR
- Tscan Therapeutics, Inc. (TCRX) filed form 8-K · 2026-08-12 · SEC EDGAR
Ask the AI about TCRX
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →